%0 Journal Article
%T Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
%A Carlota Grifols
%A Laura N¨²£¿ez
%A Merc¨¨ Boada
%A Mireia Torres
%A Oscar L¨®pez
%A Zbigniew M. Szczepiorkowski
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2019
%R 10.1016/j.trci.2019.01.001
%X Preliminary studies have shown that treatment with plasma exchange (PE) plus therapeutic albumin replacement in patients with Alzheimer's disease (AD) induced mobilization of plasma and cerebrospinal fluid amyloid ¦Â protein, associated with an improvement in memory and language functions, as well as the stabilization of brain perfusion, which persisted after treatment discontinuation
%K Alzheimer's disease
%K Plasma exchange
%K Plasmapheresis
%K Clinical trial
%K Albumin
%K Albutein
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395854/